MHC LLP Advises Surmodics on Acquisition of Vetex Medical

08 July 2021

We are pleased to have acted for Surmodics Inc. on the acquisition of Vetex Medical Limited.

Surmodics, a Nasdaq listed medtech company based in Minnesota, is a leading provider of medical device and in vitro diagnostic technologies to the health care industry.

The deal for Galway-based Vetex expands Surmodics’ thrombectomy portfolio with a second US FDA approved device, the ReVene Thrombectomy Catheter. This device developed by Vetex is specifically designed to remove large, mixed-morphology blood clots commonly found with venous thromboembolism.

Discuss your related queries now with Martin Kelleher.

  • LinkedIn